No photo of Maeve Shannon

Maeve Shannon

Dr

  • Room 01.327 - David Keir Building

    United Kingdom

20162019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2019
Open Access
File
1 Citation (Scopus)
53 Downloads (Pure)
2017

The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like-peptide-1 (GLP-1) gut hormone and GLP-1 receptor interaction

Shannon, M., Green, B., Willars, G., Wilson, J., Matthews, N., Lamb, J., Gillespie, A. & Connolly, L., 04 Jan 2017, In : Toxicology Letters. 265, p. 97-105 9 p.

Research output: Contribution to journalArticle

Open Access
File
6 Citations (Scopus)
369 Downloads (Pure)
2016

An in vitro investigation on the cytotoxic and nuclear receptor transcriptional activity of the mycotoxins fumonisin B1 and beauvericin

Fernández-Blanco, C., Frizzell, C., Shannon, M., Ruiz, M-J. & Connolly, L., 22 Aug 2016, In : Toxicology Letters. 257, p. 1-10 10 p.

Research output: Contribution to journalArticle

Open Access
File
16 Citations (Scopus)
183 Downloads (Pure)

In vitro bioassay investigations of the endocrine disrupting potential of steviol glycosides and their metabolite steviol, components of the natural sweetener Stevia

Shannon, M., Rehfeld, A., Frizzell, C., Livingstone, C., McGonagle, C., Skakkebaek, N. E., Wielogórska, E. & Connolly, L., 15 May 2016, In : Molecular and Cellular Endocrinology. 427, p. 65-72

Research output: Contribution to journalArticle

Open Access
File
8 Citations (Scopus)
521 Downloads (Pure)